Chordia Therapeutics Inc. (JP:190A) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Chordia Therapeutics Inc. is committed to launching innovative drugs with novel mechanisms of action, aiming for sustainable sales and growth. The company emphasizes strong corporate governance to enhance trust and adapt to changing business environments, with Takeda Pharmaceutical Company Limited as its largest shareholder. Despite being a small player in the pharmaceutical sector, Chordia is listed on the Growth Market and is focused on strengthening its organizational structure for long-term success.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ZMI, TBAL: 2 Canadian Balanced ETFs to Shield Your Returns
- Class Action Lawsuit Against Paragon 28, Inc. (NYSE:FNA)
- 3 Penny Stocks to Watch Now, 11/29/24
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
